---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-020811"
form_type: "8-K/A"
ticker: "REFI"
cik: "0001867949"
company_name: "Chicago Atlantic Real Estate Finance, Inc."
filed_at: "2022-04-20T23:59:59+00:00"
generated_at: "2026-06-26T06:18:09.177654+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Chicago Atlantic REFI amends 8-K; determines no borrower financials required for FarmaceuticalRX loan

## Summary
- Amendment to February 8, 2022 8-K regarding $ loan commitment to FarmaceuticalRX LLC.
- Re-evaluated significance using FY 2021 financial statements filed April 14, 2022.
- Determined audited financials of Borrowers under Rule 3-14 are not required.
- No pro forma financial information required either.
- Filing is procedural; no change in loan terms or business operations.

## SEC filing metadata
- accession: 0001213900-22-020811
- form_type: 8-K/A
- ticker: REFI
- cik: 0001867949
- company_name: Chicago Atlantic Real Estate Finance, Inc.
- filed_at: 2022-04-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867949/000121390022020811/0001213900-22-020811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867949/000121390022020811/ea158672-8k_chiatl.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-020811
- JSON: https://secwatch.observer/filing/0001213900-22-020811.json
- Plain text: https://secwatch.observer/filing/0001213900-22-020811.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.